Who uses our work?

Our research is used by a range of organisations and individuals responsible for supporting the delivery of efficient health care.

Our work has been used by federal and state governments, health service providers, public health organisations, other researchers and students. It’s also available to the general public who are keen to learn more about the cost and value of health interventions.

Our work in use

Deakin Health Economics undertakes a wide range of grant funded and commission/tender funded research. Victorian government departments that DHE has undertaken projects for include:

  • the Victorian Department of Health and Human Services
  • the Victorian Department of Treasury and Finance.

Australian Government departments include:

  • the Department of Health
  • Health Workforce Australia

Non-government organisations include:

  • Orygen Youth Mental Health
  • National Heart Foundation of Australia
  • National Stroke Foundation
  • Diabetes Victoria
  • Dental Hospital Victoria
  • Cancer Council Victoria
  • Movember
  • the Gutsy Group
  • the Murdoch Childrens Research Institute

We invite you to use the learnings to guide your contribution to the debate on how to design a system for health that values effectiveness, equity and efficiency, and how we can improve preventive action on the basis of the best available evidence.




DHE has also collaborated with colleagues in Australian and overseas universities, including:

  • Monash University
  • University of Melbourne
  • University of Sydney
  • University of Technology Qld
  • University of Queensland
  • Flinders University
  • Australian Catholic University
  • Victoria University
  • Oxford University
  • Harvard University.

Highly-accessed reports

Assessing cost effectiveness (ACE) in prevention

This report evaluates 150 prevention interventions to inform which programs deliver value for money across a range of clinical areas.

View the full report on the University of Queensland website

The health and economic benefits of reducing disease risk factors

This report looks at the health and economics benefits of reducing disease risk factors. It quantifies the health status, financial and economic benefits of reducing the prevalence of the six behavioural risk factors: obesity, alcohol, smoking, exercise, diet and domestic violence.

View the full report on the VicHealth website

Osteoporosis costing all Australians: A new burden of disease analysis 2012 to 2022

This report estimates the current and future economic costs of osteoporosis in Australia.

View the full report on the Osteoporosis Australia website

Highly accessed journal papers

Gortmaker SL, Swinburn BA, Levy D, Carter R, Mabry PL, Finegood DT, Huang T, Marsh T, Moodie ML: Changing the future of obesity: science, policy, and action. The Lancet, 378:838–847.

Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P: Is early intervention in psychosis cost-effective over the long term? Schizophr Bull 2009, 35:909–918.

Shiell A, Hawe P, Gold L: Complex interventions or complex systems? Implications for health economic evaluation. BMJ 2008, 336:1281–1283.

Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL: The global obesity pandemic: shaped by global drivers and local environments. The Lancet, 378:804–814.